As of 2024-12-13, the Intrinsic Value of Biocure Technology Inc (CURE.CN) is
-2.16 CAD. This CURE.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.03 CAD, the upside of Biocure Technology Inc is
-7,298.72%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-2.16 CAD
Intrinsic Value
CURE.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-2.16 - -2.16 |
-2.16 |
-7,298.72% |
| DDM - Stable |
(1.44) - (8.60) |
(5.02) |
-16843.9% |
| DDM - Multi |
(1.56) - (7.53) |
(2.62) |
-8831.5% |
CURE.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
0.31 |
| Beta |
-0.64 |
| Outstanding shares (mil) |
10.44 |
| Enterprise Value (mil) |
0.35 |
| Market risk premium |
5.10% |
| Cost of Equity |
8.31% |
| Cost of Debt |
5.00% |
| WACC |
7.76% |